Inventor · disambiguated record
Ronald J. Berenson
Also filed as: BERENSON RONALD · BERENSON RONALD J · BERENSON RONALD JAY
29 granted patents·33 pending applications·3,680 citations·filing 1990–2024
97Inventor score
Files withXCYTE THERAPIES INC15KITOTECH MEDICAL INC7BERENSON RONALD J4HEMAQUEST PHARMACEUTICALS INC4INVITROGEN CORP4
Top patents by PatentIndex Score
62 records- 0197US6905874B2Simultaneous stimulation and concentration of cellsXCYTE THERAPIES INC·Filed 2001·Granted Jun 14, 2005·950 cites·43 claims
- 0297US6867041B2Simultaneous stimulation and concentration of cellsXCYTE THERAPIES INC·Filed 2002·Granted Mar 15, 2005·935 cites·21 claims
- 0397US6797514B2Simultaneous stimulation and concentration of cellsXCYTE THERAPIES INC·Filed 2001·Granted Sep 28, 2004·985 cites·14 claims
- 0496US9528088B2Methods for eliminating at least a substantial portion of a clonal antigen-specific memory T cell subpopulationLIFE TECHNOLOGIES CORP·Filed 2013·Granted Dec 27, 2016·35 cites·6 claims
- 0596US7572631B2Activation and expansion of T cellsINVITROGEN CORP·Filed 2005·Granted Aug 11, 2009·217 cites·7 claims
- 0695US8617884B2Methods for eliminating at least a substantial portion of a clonal antigen-specific memory T cell subpopulationBERENSON RONALD J·Filed 2008·Granted Dec 31, 2013·37 cites·6 claims
- 0794US5635387AMethods and device for culturing human hematopoietic cells and their precursorsCELLPRO INC·Filed 1995·Granted Jun 3, 1997·317 cites·28 claims
- 0891US11957346B2Force modulating deep skin staples and instrumentsKITOTECH MEDICAL INC·Filed 2023·Granted Apr 16, 2024·2 cites·24 claims
- 0991US10857152B2Methods and compositions for treating viral or virally-induced conditionsVIRACTA THERAPEUTICS INC·Filed 2018·Granted Dec 8, 2020·3 cites·11 claims
- 1090US8821945B2Method for transdermal iontophoretic delivery of chelated agentsIMRAN MIR·Filed 2009·Granted Sep 2, 2014·6 cites·41 claims
- 1188US10939912B2Microstructure-based systems, apparatus, and methods for wound closureKITOTECH MEDICAL INC·Filed 2017·Granted Mar 9, 2021·13 cites·23 claims
- 1288US2024390375A1Methods and compositions for treating viral or virally-induced conditionsVIRACTA SUBSIDIARY INC·Filed 2024·Application pending·0 cites
- 1387US8996104B2Patches and method for the transdermal delivery of a therapeutically effective amount of ironBERENSON RONALD J·Filed 2009·Granted Mar 31, 2015·7 cites·42 claims
- 1482US8618068B2Methods and low dose regimens for treating red blood cell disordersPERRINE SUSAN P·Filed 2010·Granted Dec 31, 2013·6 cites·29 claims
- 1580US12083119B2Methods and compositions for treating viral or virally-induced conditionsVIRACTA SUBSIDIARY INC·Filed 2021·Granted Sep 10, 2024·0 cites·4 claims
- 1679US7541184B2Activation and expansion of cellsINVITROGEN CORP·Filed 2004·Granted Jun 2, 2009·10 cites·2 claims
- 1778US9580553B2Thermally-activated self-immolative materialsUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2013·Granted Feb 28, 2017·3 cites·25 claims
- 1876US2024342172A1Methods and compositions for treating viral or virally-induced conditionsVIRACTA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1975US12290260B2Force modulating deep skin staples and instrumentsKITOTECH MEDICAL INC·Filed 2024·Granted May 6, 2025·0 cites·21 claims
- 2075US9913806B2Patches and methods for the transdermal delivery of a therapeutically effective amount of ironBERENSON RONALD J·Filed 2009·Granted Mar 13, 2018·1 cites·20 claims
- 2174US2024366222A1Microstructure-based systems, apparatus, and methods for wound closureKITOTECH MEDICAL INC·Filed 2024·Application pending·0 cites
- 2270US5378624AMethods for removing ligands from a particle surfaceCELLPRO INC·Filed 1990·Granted Jan 3, 1995·45 cites·8 claims
- 2370US2013331313A1Methods and compositions for treating viral or virally-induced conditionsUNIV BOSTON·Filed 2013·Application pending·0 cites
- 2468US2024285921A1Microstructure systems and methods for pain treatmentAUDELL ROBERT ARMAN·Filed 2024·Application pending·0 cites
- 2568US2017042898A1Methods and compositions for treating viral or virally-induced conditionsHEMAQUEST PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2667US11931040B2Microstructure-based systems, apparatus, and methods for wound closureKITOTECH MEDICAL INC·Filed 2021·Granted Mar 19, 2024·0 cites·20 claims
- 2767US2023255630A1Wound closure device for wide treatment areasLEUNG CHEUK YIN PAUL·Filed 2023·Application pending·0 cites
- 2866US2020071663A1Methods for eliminating at least a substantial portion of a clonal antigen-specific memory t cell subpopulationLIFE TECHNOLOGIES CORP·Filed 2019·Application pending·0 cites
- 2965US9402904B2Method for transdermal iontophoretic delivery of chelated agentsFE3 MEDICAL INC·Filed 2014·Granted Aug 2, 2016·0 cites·38 claims
- 3065US2010092436A1Compositions and methods for restoring immune responsiveness in patients with immunological defectsBONYHADI MARK·Filed 2009·Application pending·0 cites
- 3164US10751050B2Microstructure-based wound closure devicesUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2013·Granted Aug 25, 2020·5 cites·20 claims
- 3264US2016113929A1Methods and compositions for treating viral or virally-induced conditionsHEMAQUEST PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3362US11986613B2Microstructure systems and methods for pain treatmentKITOTECH MEDICAL INC·Filed 2021·Granted May 21, 2024·0 cites·7 claims
- 3462US2005153447A1Activation and expansion of cellsXCYTE THERAPIES INC·Filed 2004·Application pending·0 cites
- 3562US2005214942A1Activation and expansion of cellsXCYTE THERAPIES INC·Filed 2004·Application pending·0 cites
- 3659US2005084967A1Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantationXCYTE THERAPIES INC·Filed 2004·Application pending·0 cites
- 3758US2017114321A1Methods for eliminating at least a substantial portion of a clonal antigen-specific memory t cell subpopulationLIFE TECHNOLOGIES CORP·Filed 2016·Application pending·0 cites
- 3858US2011245154A1Methods and Compositions for Treating Viral or Virally-Induced ConditionsHEMAQUEST PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 3958US2007274974A1Compositions and methods for restoring immune responsiveness in patients with immunological defectsINVITROGEN CORP·Filed 2007·Application pending·0 cites
- 4056US2003119185A1Activation and expansion of cellsXCYTE THERAPIES INC·Filed 2002·Application pending·0 cites
- 4155US2018333367A1Patches and Methods for the Transdermal Delivery of a Therapeutically Effective Amount of IronFE3 MEDICAL INC·Filed 2018·Application pending·0 cites
- 4255US2021251628A1Elastic and flexible wound closure deviceKITOTECH MEDICAL INC·Filed 2021·Application pending·0 cites
- 4354US2008267972A1Donor Lymphocyte Infusion of T Cells For the Treatment of CancerINVITROGEN CORP·Filed 2006·Application pending·0 cites
- 4454US2004175373A1Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantationXCYTE THERAPIES INC·Filed 2003·Application pending·0 cites
- 4554US2005118173A1Compositions and methods to accelerate hematologic recoveryXCYTE THERAPIES INC·Filed 2004·Application pending·0 cites
- 4654US2006286089A1Compositions and methods for the treatment of burns and sepsisXCYTE THERAPIES INC·Filed 2006·Application pending·0 cites
- 4752US2004005298A1Compositions and methods for restoring immune responsiveness in patients with immunological defectsXCYTE THERAPIES INC·Filed 2003·Application pending·0 cites
- 4851US10463629B2Patches and methods for the transdermal delivery of a therapeutically effective amount of ironFE3 MEDICAL INC·Filed 2015·Granted Nov 5, 2019·0 cites·46 claims
- 4949US2003082806A1Maturation of antigen-presenting cells using activated T cellsXCYTE THERAPIES INC·Filed 2002·Application pending·0 cites
- 5048US2020345366A1Microstructure-based wound closure devicesUNIV WASHINGTON·Filed 2020·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ronald J. Berenson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →